FollowMyHealth Patient Portal

Matthew A. Ciorba, MD

Assistant Professor, Medicine
Division of Gastroenterology

Specialty Areas

Gastroenterology
Gastrointestinal Disease
Inflammatory Bowel Disease

Board Certifications

Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Areas of Clinical Interest

Gastroenterology, inflammatory bowel disease, Crohn's disease

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Center for Advanced Medicine

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 8
Office Phone: 314-747-2066

Education

Education

Fellowship: Gastroenterology, Washington University School of Medicine, St. Louis, Missouri 2007
Residency: Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 2003
M.D.: University of Iowa College of Medicine, Iowa City, Iowa 2001
B.S.: Exercise Science, University of Iowa College of Liberal Arts, Iowa City, Iowa 1996

Publication & Research

Publication & Research

Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions.
Sheikh A, Rashu R, Begum YA, Kuhlman FM, Ciorba MA, Hultgren SJ, Qadri F, Fleckenstein JM
PLoS Negl Trop Dis. 2017 May; 11(5)e0005586. doi: 10.1371/journal.pntd.0005586.

PMID:
    28531220
    [PubMed - in process]
Related citations


Pneumococcal Disease in Inflammatory Bowel Disease: Justification to Vaccinate at Diagnosis.
Cushing KC, Kanuri N, Ciorba MA
Gastroenterology. 2016 Aug; 151(2)365-6. doi: 10.1053/j.gastro.2016.06.027.

PMID:
    27375193
    [PubMed - in process]
Related citations


Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.
Christophi GP, Rengarajan A, Ciorba MA
Clin Exp Gastroenterol. 2016; 9125-30. doi: 10.2147/CEG.S80237.

PMID:
    27274301
    [PubMed]
Related citations


Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in irritable bowel syndrome.
Patel A, Hasak S, Cassell B, Ciorba MA, Vivio EE, Kumar M, Gyawali CP, Sayuk GS
Aliment Pharmacol Ther. 2016 Aug; 44(3)246-58. doi: 10.1111/apt.13677.

PMID:
    27240555
    [PubMed - in process]
Related citations


Probiotic Gut Bacteria Enhance Cancer Immunotherapy in a Mouse Model of Melanoma.
Dey N, Ciorba MA
Gastroenterology. 2016 Jul; 151(1)206-7. doi: 10.1053/j.gastro.2016.05.015.

PMID:
    27238844
    [PubMed - in process]
Related citations


Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera.
Kuhlmann FM, Santhanam S, Kumar P, Luo Q, Ciorba MA, Fleckenstein JM
Am J Trop Med Hyg. 2016 Aug 3; 95(2)440-3. doi: 10.4269/ajtmh.16-0161.

PMID:
    27162272
    [PubMed - indexed for MEDLINE]
Related citations


Advances in understanding and improving gastrointestinal symptoms during supportive and palliative care: a decade of progress.
Ciorba MA
Curr Opin Support Palliat Care. 2016 Jun; 10(2)149-51. doi: 10.1097/SPC.0000000000000215.

PMID:
    27054289
    [PubMed - in process]
Related citations


Vedolizumab Effectiveness and Safety Over the First Year of Use in an IBD Clinical Practice.
Vivio EE, Kanuri N, Gilbertsen JJ, Monroe K, Dey N, Chen CH, Gutierrez AM, Ciorba MA
J Crohns Colitis. 2016 Apr; 10(4)402-9. doi: 10.1093/ecco-jcc/jjv226.

PMID:
    26681763
    [PubMed - indexed for MEDLINE]
Related citations


Butyrate and Mucosal Inflammation: New Scientific Evidence Supports Clinical Observation.
Cushing K, Alvarado DM, Ciorba MA
Clin Transl Gastroenterol. 2015 Aug 27; 6e108. doi: 10.1038/ctg.2015.34.

PMID:
    26312412
    [PubMed]
Related citations


Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.
Santhanam S, Alvarado DM, Ciorba MA
Transl Res. 2016 Jan; 167(1)67-79. doi: 10.1016/j.trsl.2015.07.003.

PMID:
    26297050
    [PubMed - indexed for MEDLINE]
Related citations


Correction: IDO1 and IDO2 Non-Synonymous Gene Variants: Correlation with Crohn's Disease Risk and Clinical Phenotype.
Lee A, Kanuri N, Zhang Y, Sayuk GS, Li E, Ciorba MA
PLoS One. 2015; 10(7)e0133098. doi: 10.1371/journal.pone.0133098.

PMID:
    26173109
    [PubMed]
Related citations


Scap and the intestinal epithelial stem cell niche: new insights from lipid biology.
Ciorba MA
J Lipid Res. 2015 Aug; 56(8)1381-2. doi: 10.1194/jlr.C061309.

PMID:
    26063459
    [PubMed - indexed for MEDLINE]
Related citations


Lower Dose Infliximab for Ulcerative Colitis: How Low Can We Go and How Much Can be Saved?
Christophi GP, Ciorba MA
J Clin Gastroenterol. 2015 Aug; 49(7)539-40. doi: 10.1097/MCG.0000000000000352.

PMID:
    26057322
    [PubMed - indexed for MEDLINE]
Related citations


Probiotics to prevent gastrointestinal toxicity from cancer therapy: an interpretive review and call to action.
Ciorba MA, Hallemeier CL, Stenson WF, Parikh PJ
Curr Opin Support Palliat Care. 2015 Jun; 9(2)157-62. doi: 10.1097/SPC.0000000000000134.

PMID:
    25872116
    [PubMed - indexed for MEDLINE]
Related citations


IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.
Lee A, Kanuri N, Zhang Y, Sayuk GS, Li E, Ciorba MA
PLoS One. 2014; 9(12)e115848. doi: 10.1371/journal.pone.0115848.

PMID:
    25541686
    [PubMed - indexed for MEDLINE]
Related citations


Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays.
VanDussen KL, Marinshaw JM, Shaikh N, Miyoshi H, Moon C, Tarr PI, Ciorba MA, Stappenbeck TS
Gut. 2015 Jun; 64(6)911-20. doi: 10.1136/gutjnl-2013-306651.

PMID:
    25007816
    [PubMed - indexed for MEDLINE]
Related citations


Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.
Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T, Ciorba MA, Sayuk GS
J Clin Gastroenterol. 2014 May-Jun; 48(5)423-9. doi: 10.1097/MCG.0000000000000049.

PMID:
    24406434
    [PubMed - indexed for MEDLINE]
Related citations


Kynurenine pathway metabolites: relevant to vitamin B-6 deficiency and beyond.
Ciorba MA
Am J Clin Nutr. 2013 Oct; 98(4)863-4. doi: 10.3945/ajcn.113.072025.

PMID:
    23985806
    [PubMed - indexed for MEDLINE]
Related citations


IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI, Rao MS, Bishnupuri KS, Kerr TA, Foster L, Marinshaw JM, Newberry RD, Stenson WF, Ciorba MA
Gastroenterology. 2013 Aug; 145(2)416-25.e1-4. doi: 10.1053/j.gastro.2013.05.002.

PMID:
    23669411
    [PubMed - indexed for MEDLINE]
Related citations


Indoleamine 2,3 dioxygenase in intestinal disease.
Ciorba MA
Curr Opin Gastroenterol. 2013 Mar; 29(2)146-52. doi: 10.1097/MOG.0b013e32835c9cb3.

PMID:
    23283180
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following earned financial interests during calendar year 2016.

Company Name: Abbott/AbbVie

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $50,001 - $100,000

Reporting Date: May 01, 2017


Company Name: Takeda

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $50,001 - $100,000

Reporting Date: May 01, 2017